Pathology of hereditary breast cancer

Cellular Oncology

Volumn 34, Issue 2, 2011, Pages 71-88

  Van Der Groep, Petra ^a   Van Der Wall, Elsken ^a   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

BRCA1; BRCA2; Genetics; Hereditary breast cancer; Pathology

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CASPASE 3; CAVEOLIN 1; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MISMATCH REPAIR PROTEIN PMS2; NIBRIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE LKB1; PROTEIN P53; RAD50 PROTEIN; UVOMORULIN; VIMENTIN; BRCA1 PROTEIN; BRCA2 PROTEIN;

AFRICAN AMERICAN; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CANCER; BREAST FIBROADENOMA; CANCER PATIENT; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; FANCONI ANEMIA; FRAMESHIFT MUTATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE INSERTION; GENE MUTATION; GENE STRUCTURE; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; JAPANESE; M PHASE CELL CYCLE CHECKPOINT; MASTECTOMY; MISMATCH REPAIR; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NONSENSE MUTATION; NUCLEAR LOCALIZATION SIGNAL; PENETRANCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOLOGY; REVIEW;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION;

EID: 79960902938     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0010-3     Document Type: Article

References (206)

1. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349, 1505-1510 (1997)
2. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br. J. Cancer 83, 1301-1308 (2000)
3. C. Adem, C.L. Soderberg, K. Hafner, C. Reynolds, J.M. Slezak, C.S. Sinclair, T.A. Sellers, D.J. Schaid, F. Couch, L.C. Hartmann, R.B. Jenkins, ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes Chromosom. Cancer 41, 1-11 (2004) (Pubitemid 38988733)
4. B.A. Agnarsson, J.G. Jonasson, I.B. Bjornsdottir, R.B. Barkardottir, V. Egilsson, H. Sigurdsson, Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res. Treat. 47, 121- 127 (1998) (Pubitemid 28046083)
5. M. Allinen, P. Huusko, S. Mantyniemi, V. Launonen, R. Winqvist, Mutation analysis of the CHK2 gene in families with hereditary breast cancer. Br. J. Cancer 85, 209-212 (2001) (Pubitemid 32695741)
6. J. Alsner, M. Yilmaz, P. Guldberg, L.L. Hansen, J. Overgaard, Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin. Cancer Res. 6, 3923-3931 (2000)
7. T.I. Andersen, A.L. Borresen, P. Moller, A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am. J. Hum. Genet. 59, 486-487 (1996) (Pubitemid 26266372)
8. A.C. Antoniou, D.F. Easton, Models of genetic susceptibility to breast cancer. Oncogene 25, 5898-5905 (2006) (Pubitemid 44453445)
9. A.C. Antoniou, P.D. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, H. Olsson, O. Johannsson, A. Borg, B. Pasini, P. Radice, S. Manoukian, D.M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjakoski, O.P. Kallioniemi, D. Thompson, C. Evans, J. Peto, F. Lalloo, D.G. Evans, D.F. Easton, Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: A combined analysis of 22 population based studies. J. Med. Genet. 42, 602-603 (2005) (Pubitemid 40993838)
10. J.E. Armes, A.J. Egan, M.C. Southey, G.S. Dite, M.R. McCredie, G.G. Giles, J.L. Hopper, D.J. Venter, The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study. Cancer 83, 2335-2345 (1998) (Pubitemid 28533503)
11. J.E. Armes, L. Trute, D. White, M.C. Southey, F. Hammet, A. Tesoriero, A.M. Hutchins, G.S. Dite, M.R.McCredie, G.G. Giles, J. L. Hopper, D.J. Venter, Distinct molecular pathogeneses of earlyonset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study. Cancer Res. 59, 2011-2017 (1999) (Pubitemid 29186179)
12. J.B. Arnes, J.S. Brunet, I. Stefansson, L.R. Begin, N. Wong, P.O. Chappuis, L.A. Akslen, W.D. Foulkes, Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin. Cancer Res. 11, 4003-4011 (2005) (Pubitemid 40791563)
13. B. Arun, K.J. Vogel, A. Lopez, M. Hernandez, D. Atchley, K.R. Broglio, C.I. Amos, F. Meric-Bernstam, H. Kuerer, G.N. Hortobagyi, C.T. Albarracin, High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers. Cancer Prev. Res. (Phila. Pa.) 2, 122-127 (2009)
14. A.L. Bane, J.C. Beck, I. Bleiweiss, S.S. Buys, E. Catalano, M.B. Daly, G. Giles, A.K. Godwin, H. Hibshoosh, J.L. Hopper, E.M. John, L. Layfield, T. Longacre, A. Miron, R. Senie, M.C. Southey, D.W. West, A.S. Whittemore, H. Wu, I.L. Andrulis, F.P. O'Malley, BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am. J. Surg. Pathol. 31, 121- 128 (2007) (Pubitemid 46036911)
15. A.L. Bane, D. Pinnaduwage, S. Colby, S.B. Bull, F.P. O'Malley, I.L. Andrulis, Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. Breast Cancer Res. Treat. (2008)
16. R.B. Bar-Sade, A. Kruglikova, B. Modan, E. Gak, G. Hirsh-Yechezkel, L. Theodor, I. Novikov, R. Gershoni-Baruch, S. Risel, M.Z. Papa, G. Ben-Baruch, E. Friedman, The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum. Mol. Genet. 7, 801-805 (1998) (Pubitemid 28221242)
17. K.F. Becker, M.J. Atkinson, U. Reich, I. Becker, H. Nekarda, J.R. Siewert, H. Hofler, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54, 3845-3852 (1994) (Pubitemid 24241205)
18. D.W. Bell, J.M. Varley, T.E. Szydlo, D.H. Kang, D.C. Wahrer, K. E. Shannon, M. Lubratovich, S.J. Verselis, K.J. Isselbacher, J.F. Fraumeni, J.M. Birch, F.P. Li, J.E. Garber, D.A. Haber, Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528-2531 (1999)
19. V. Birgisdottir, O.A. Stefansson, S.K. Bodvarsdottir, H. Hilmarsdottir, J.G. Jonasson, J.E. Eyfjord, Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res. 8, R38 (2006)
20. N. Bogdanova, P. Schurmann, R. Waltes, S. Feshchenko, I.V. Zalutsky, M. Bremer, T. Dork, NBS1 variant I171V and breast cancer risk. Breast Cancer Res. Treat. 112, 75-79 (2008)
21. R. Bos, P. van der Groep, A.E. Greijer, A. Shvarts, S. Meijer, H. M. Pinedo, G.L. Semenza, P.J. van Diest, E. van der Wall, Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97, 1573-1581 (2003) (Pubitemid 36297788)
22. R. Bos, H. Zhong, C.F. Hanrahan, E.C. Mommers, G.L. Semenza, H.M. Pinedo, M.D. Abeloff, J.W. Simons, P.J. van Diest, E. van der Wall, Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93, 309-314 (2001) (Pubitemid 32219818)
23. C.T. Brekelmans, C. Seynaeve, M. Menke-Pluymers, H.T. Bruggenwirth, M.M. Tilanus-Linthorst, C.C. Bartels, M. Kriege, A.N. van Geel, C.M. Crepin, J.C. Blom, H. Meijers-Heijboer, J. G. Klijn, Survival and prognostic factors in BRCA1-associated breast cancer. Ann. Oncol. 17, 391-400 (2006) (Pubitemid 43329574)
24. Broca, Traite des tumeurs (1866)
25. H.E. Bryant, N. Schultz, H.D. Thomas, K.M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N.J. Curtin, T. Helleday, Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase. Nature 434, 913-917 (2005) (Pubitemid 40559005)
26. T. Byrski, T. Huzarski, R. Dent, J. Gronwald, D. Zuziak, C. Cybulski, J. Kladny, B. Gorski, J. Lubinski, S.A. Narod, Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res. Treat. (2008)
27. I. Callebaut, J.P. Mornon, From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair. FEBS Lett. 400, 25-30 (1997) (Pubitemid 27046815)
28. I. Cass, R.L. Baldwin, T. Varkey, R. Moslehi, S.A. Narod, B.Y. Karlan, Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97, 2187-2195 (2003) (Pubitemid 36444059)
29. P.O. Chappuis, V. Nethercot, W.D. Foulkes, Clinico-pathological characteristics of BRCA1-and BRCA2-related breast cancer. Semin. Surg. Oncol. 18, 287-295 (2000) (Pubitemid 30253021)
30. G. Chenevix-Trench, S. Healey, S. Lakhani, P. Waring, M. Cummings, R. Brinkworth, A.M. Deffenbaugh, L.A. Burbidge, D. Pruss, T. Judkins, T. Scholl, A. Bekessy, A. Marsh, P. Lovelock, M. Wong, A. Tesoriero, H. Renard, M. Southey, J.L. Hopper, K. Yannoukakos, M. Brown, D. Easton, S.V. Tavtigian, D. Goldgar, A.B. Spurdle, Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res. 66, 2019-2027 (2006)
31. E.B. Claus, J. Schildkraut, E.S. Iversen Jr., D. Berry, G. Parmigiani, Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J. Natl. Cancer Inst. 90, 1824-1829 (1998) (Pubitemid 28559895)
32. N. Collins, R. McManus, R. Wooster, J. Mangion, S. Seal, S.R. Lakhani, W. Ormiston, P.A. Daly, D. Ford, D.F. Easton et al., Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10, 1673-1675 (1995)
33. R.S. Cornelis, S.L. Neuhausen, O. Johansson, A. Arason, D. Kelsell, B.A. Ponder, P. Tonin, U. Hamann, A. Lindblom, P. Lalle et al., High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosom. Cancer 13, 203-210 (1995)
34. T. Crook, L.A. Brooks, S. Crossland, P. Osin, K.T. Barker, J.Waller, E. Philp, P.D. Smith, I. Yulug, J. Peto, G. Parker, M.J. Allday, M.R. Crompton, B.A. Gusterson, p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1-and BRCA2-associated breast tumours. Oncogene 17, 1681-1689 (1998) (Pubitemid 28482645)
35. A.D. D'Andrea, M. Grompe, The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3, 23-34 (2003) (Pubitemid 37328884)
36. O.R. Davies, L. Pellegrini, Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats. Nat. Struct. Mol. Biol. 14, 475-483 (2007) (Pubitemid 46871813)
37. A.M. Dworkin, A.D. Spearman, S.Y. Tseng, K. Sweet, A.E. Toland, Methylation not a frequent "second hit" in tumors with germline BRCA mutations. Fam. Cancer 8, 339-346 (2009)
38. H. Eerola, P. Heikkila, A. Tamminen, K. Aittomaki, C. Blomqvist, H. Nevanlinna, Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families. Breast Cancer Res. 7, R465-R469 (2005)
39. A. Eisen, J. Lubinski, J. Gronwald, P. Moller, H.T. Lynch, J. Klijn, C. Kim-Sing, S.L. Neuhausen, L. Gilbert, P. Ghadirian, S. Manoukian, G. Rennert, E. Friedman, C. Isaacs, E. Rosen, B. Rosen, M. Daly, P. Sun, S.A. Narod, Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J. Natl. Cancer Inst. 100, 1361-1367 (2008)
40. F. Esashi, V.E. Galkin, X. Yu, E.H. Egelman, S.C. West, Stabilization of RAD51 nucleoprotein filaments by the Cterminal region of BRCA2. Nat. Struct. Mol. Biol. 14, 468- 474 (2007) (Pubitemid 46871809)
41. M. Esteller, M.F. Fraga, M. Guo, J. Garcia-Foncillas, I. Hedenfalk, A.K. Godwin, J. Trojan, C. Vaurs-Barriere, Y.J. Bignon, S. Ramus, J. Benitez, T. Caldes, Y. Akiyama, Y. Yuasa, V. Launonen, M.J. Canal, R. Rodriguez, G. Capella, M.A. Peinado, A. Borg, L.A. Aaltonen, B.A. Ponder, S.B. Baylin, J.G. Herman, DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001- 3007 (2001) (Pubitemid 34083486)
42. M. Esteller, J.M. Silva, G. Dominguez, F. Bonilla, X. Matias-Guiu, E. Lerma, E. Bussaglia, J. Prat, I.C. Harkes, E.A. Repasky, E. Gabrielson, M. Schutte, S.B. Baylin, J.G. Herman, Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92, 564-569 (2000) (Pubitemid 30212318)
43. H. Farmer, N. McCabe, C.J. Lord, A.N. Tutt, D.A. Johnson, T.B. Richardson, M. Santarosa, K.J. Dillon, I. Hickson, C. Knights, N.M. Martin, S.P. Jackson, G.C. Smith, A. Ashworth, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917-921 (2005) (Pubitemid 40559006)
44. W.D. Foulkes, J.S. Brunet, I.M. Stefansson, O. Straume, P.O. Chappuis, L.R. Begin, N. Hamel, J.R. Goffin, N. Wong, M. Trudel, L. Kapusta, P. Porter, L.A. Akslen, The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res. 64, 830-835 (2004) (Pubitemid 38176880)
45. W.D. Foulkes, I.M. Stefansson, P.O. Chappuis, L.R. Begin, J.R. Goffin, N. Wong, M. Trudel, L.A. Akslen, Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J. Natl. Cancer Inst. 95, 1482-1485 (2003) (Pubitemid 37279334)
46. P. Freneaux, D. Stoppa-Lyonnet, E. Mouret, M. Kambouchner, A. Nicolas, B. Zafrani, A. Vincent-Salomon, A. Fourquet, H. Magdelenat, X. Sastre-Garau, Low expression of bcl-2 in Brca1-associated breast cancers. Br. J. Cancer 83, 1318-1322 (2000)
47. Y. Galanty, R. Belotserkovskaya, J. Coates, S. Polo, K.M. Miller, S.P. Jackson, Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462, 935-939 (2009)
48. Q. Gao, S. Neuhausen, S. Cummings, M. Luce, O.I. Olopade, Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am. J. Hum. Genet. 60, 1233-1236 (1997) (Pubitemid 27194108)
49. M. Gasco, I.G. Yulug, T. Crook, TP53 mutations in familial breast cancer: Functional aspects. Hum. Mutat. 21, 301-306 (2003) (Pubitemid 36292972)
50. S.A. Gayther, P. Harrington, P. Russell, G. Kharkevich, R.F. Garkavtseva, B.A. Ponder, Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet. 60, 1239-1242 (1997) (Pubitemid 27194110)
51. F.M. Giardiello, J.D. Brensinger, A.C. Tersmette, S.N. Goodman, G.M. Petersen, S.V. Booker, M. Cruz-Correa, J.A. Offerhaus, Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119, 1447-1453 (2000) (Pubitemid 32198669)
52. M.S. Greenblatt, P.O. Chappuis, J.P. Bond, N. Hamel, W.D. Foulkes, TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: Distinctive spectrum and structural distribution. Cancer Res. 61, 4092-4097 (2001) (Pubitemid 32720976)
53. T.A. Grushko, M.A. Blackwood, P.L. Schumm, F.G. Hagos, M. O. Adeyanju, M.D. Feldman, M.O. Sanders, B.L. Weber, O.I. Olopade, Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res. 62, 1481-1488 (2002) (Pubitemid 34407811)
54. J. Gudmundsson, R.B. Barkardottir, G. Eiriksdottir, T. Baldursson, A. Arason, V. Egilsson, S. Ingvarsson, Loss of heterozygosity at chromosome 11 in breast cancer: Association of prognostic factors with genetic alterations. Br. J. Cancer 72, 696-701 (1995)
55. J. Gudmundsson, G. Johannesdottir, A. Arason, J.T. Bergthorsson, S. Ingvarsson, V. Egilsson, R.B. Barkardottir, Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am. J. Hum. Genet. 58, 749-756 (1996) (Pubitemid 26086665)
56. S.A. Hahn, B. Greenhalf, I. Ellis, M. Sina-Frey, H. Rieder, B. Korte, B. Gerdes, R. Kress, A. Ziegler, J.A. Raeburn, D. Campra, R. Grutzmann, H. Rehder,M. Rothmund,W. Schmiegel, J.P. Neoptolemos, D.K. Bartsch, BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl. Cancer Inst. 95, 214-221 (2003) (Pubitemid 36240634)
57. J.M. Hall, M.K. Lee, B. Newman, J.E. Morrow, L.A. Anderson, B. Huey, M.C. King, Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689 (1990) (Pubitemid 120031871)
58. U. Hamann, Hereditary breast cancer: High risk genes, genetic testing and clinical implications. Clin. Lab. 46, 447-461 (2000)
59. A.R. Hartman, J.M. Ford, BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. 32, 180-184 (2002) (Pubitemid 34977215)
60. N. Hearle, V. Schumacher, F.H. Menko, S. Olschwang, L.A. Boardman, J.J. Gille, J.J. Keller, A.M. Westerman, R.J. Scott, W. Lim, J.D. Trimbath, F.M. Giardiello, S.B. Gruber, G.J. Offerhaus, F. W. de Rooij, J.H. Wilson, A. Hansmann, G. Moslein, B. Royer-Pokora, T. Vogel, R.K. Phillips, A.D. Spigelman, R.S. Houlston, Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin. Cancer Res. 12, 3209-3215 (2006) (Pubitemid 43837371)
61. I. Hedenfalk, D. Duggan, Y. Chen, M. Radmacher, M. Bittner, R. Simon, P. Meltzer, B. Gusterson, M. Esteller, O.P. Kallioniemi, B.Wilfond, A. Borg, J. Trent, M. Raffeld, Z. Yakhini, A. Ben-Dor, E. Dougherty, J. Kononen, L. Bubendorf, W. Fehrle, S. Pittaluga, S. Gruvberger, N. Loman, O. Johannsson, H. Olsson, G. Sauter, Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548 (2001) (Pubitemid 32167867)
62. I. Hedenfalk, M. Ringner, A. Ben-Dor, Z. Yakhini, Y. Chen, G. Chebil, R. Ach, N. Loman, H. Olsson, P.Meltzer, A. Borg, J. Trent, Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc. Natl. Acad. Sci. USA 100, 2532-2537 (2003) (Pubitemid 36297533)
63. B.A. Heemskerk-Gerritsen, C.T. Brekelmans, M.B. Menke-Pluymers, A.N. van Geel, M.M. Tilanus-Linthorst, C.C. Bartels, M. Tan, H.E. Meijers-Heijboer, J.G. Klijn, C. Seynaeve, Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: Long-term experiences at the Rotterdam Family Cancer Clinic. Ann. Surg. Oncol. 14, 3335-3344 (2007) (Pubitemid 350160099)
64. M.R. Heerma van Voss, P. van der Groep, J. Bart, E. van derWall, P. J. van Diest, Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer, In preparation
65. M.R. Heerma van Voss, P. van der Groep, J. Bart, E. van derWall, P. J. van Diest, Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers. Breast Cancer Res. Treat.
66. M.R. Heerma van Voss, P. van der Groep, J. Bart, E. van derWall, P.J. van Diest, Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls. BMC Cancer 10, 145
67. T. Heikkinen, H. Karkkainen, K. Aaltonen, R.L. Milne, P. Heikkila, K. Aittomaki, C. Blomqvist, H. Nevanlinna, The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin. Cancer Res. 15, 3214-3222 (2009)
68. T. Helleday, H.E. Bryant, N. Schultz, Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle 4, 1176-1178 (2005) (Pubitemid 41365386)
69. A. Hemminki, D. Markie, I. Tomlinson, E. Avizienyte, S. Roth, A. Loukola, G. Bignell, W. Warren, M. Aminoff, P. Hoglund, H. Jarvinen, P. Kristo, K. Pelin, M. Ridanpaa, R. Salovaara, T. Toro, W. Bodmer, S. Olschwang, A.S. Olsen, M.R. Stratton, A. de la Chapelle, L.A. Aaltonen, A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187 (1998) (Pubitemid 28092478)
70. Y.M. Hendriks, A. Wagner, H. Morreau, F. Menko, A. Stormorken, F. Quehenberger, L. Sandkuijl, P. Moller, M. Genuardi, H. Van Houwelingen, C. Tops, M. Van Puijenbroek, P. Verkuijlen, G. Kenter, A. Van Mil, H. Meijers-Heijboer, G.B. Tan, M.H. Breuning, R. Fodde, J.T. Wijnen, A.H. Brocker-Vriends, H. Vasen, Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance. Gastroenterology 127, 17-25 (2004) (Pubitemid 38962270)
71. B.B. Hermsen, P.J. van Diest, J. Berkhof, F.H. Menko, J.J. Gille, J.M. Piek, S. Meijer, H.A. Winters, P. Kenemans, S. Mensdorff-Pouilly, R.H. Verheijen, Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer. Int. J. Cancer 119, 1412-1418 (2006) (Pubitemid 44258819)
72. B.B. Hermsen, S. von Mensdorff-Pouilly, H.F. Fabry, H.A. Winters, P. Kenemans, R.H. Verheijen, P.J. van Diest, Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer. J. Pathol. 206, 220-223 (2005) (Pubitemid 40754026)
73. F.B. Hogervorst, P.M. Nederlof, J.J. Gille, C.J. McElgunn, M. Grippeling, R. Pruntel, R. Regnerus, T. van Welsem, R. van Spaendonk, F.H. Menko, I. Kluijt, C. Dommering, S. Verhoef, J. P. Schouten, L.J. van't Veer, G. Pals, Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 63, 1449-1453 (2003) (Pubitemid 36373627)
74. H. Holstege, S.A. Joosse, C.T. van Oostrom, P.M. Nederlof, A. de Vries, J. Jonkers, High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res. 69, 3625-3633 (2009)
75. E. Honrado, J. Benitez, J. Palacios, The molecular pathology of hereditary breast cancer: Genetic testing and therapeutic implications. Mod. Pathol. 18, 1305-1320 (2005) (Pubitemid 41348649)
76. E. Honrado, A. Osorio, R.L. Milne, M.F. Paz, L. Melchor, A. Cascon, M. Urioste, A. Cazorla, O. Diez, E. Lerma, M. Esteller, J. Palacios, J. Benitez, Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod. Pathol. 20, 1298-1306 (2007) (Pubitemid 350126855)
77. E. Honrado, A. Osorio, J. Palacios, J. Benitez, Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25, 5837-5845 (2006) (Pubitemid 44453439)
78. N. Hoogerbrugge, P. Bult, J.J. Bonenkamp, M.J. Ligtenberg, L. A. Kiemeney, J.A. de Hullu, C. Boetes, M.F. Niermeijer, H.G. Brunner, Numerous high-risk epithelial lesions in familial breast cancer. Eur. J. Cancer 42, 2492-2498 (2006) (Pubitemid 44442941)
79. N. Hoogerbrugge, P. Bult, L.M. de Widt-Levert, L.V. Beex, L.A. Kiemeney, M.J. Ligtenberg, L.F. Massuger, C. Boetes, P. Manders, H.G. Brunner, High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J. Clin. Oncol. 21, 41-45 (2003)
80. P. Huusko, K. Paakkonen, V. Launonen, M. Poyhonen, G. Blanco, A. Kauppila, U. Puistola, H. Kiviniemi, M. Kujala, J. Leisti, R. Winqvist, Evidence of founder mutations in Finnish BRCA1 and BRCA2 families. Am. J. Hum. Genet. 62, 1544- 1548 (1998) (Pubitemid 28307128)
81. T. Huzarski, C. Cybulski, W. Domagala, J. Gronwald, T. Byrski, M. Szwiec, S. Woyke, S.A. Narod, J. Lubinski, Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res. Treat. 90, 187-189 (2005) (Pubitemid 40568901)
82. R. Inoue, T. Fukutomi, T. Ushijima, Y. Matsumoto, T. Sugimura, M. Nagao, Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res. 55, 3521-3524 (1995)
83. J. Iscovich, M. Abdulrazik, C. Cour, A. Fischbein, J. Pe'er, D.E. Goldgar, Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int. J. Cancer 98, 42-44 (2002) (Pubitemid 34113416)
84. A.E. Isern, N. Loman, J. Malina, H. Olsson, A. Ringberg, Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. Eur. J. Surg. Oncol. 34, 1148-1154 (2008)
85. H. Joenje, F. Arwert, Connecting Fanconi anemia to BRCA1. Nat. Med. 7, 406-407 (2001) (Pubitemid 32298534)
86. O. Johannsson, E.A. Ostermeyer, S. Hakansson, L.S. Friedman, U. Johansson, G. Sellberg, K. Brondum-Nielsen, V. Sele, H. Olsson, M.C. King, A. Borg, Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am. J. Hum. Genet. 58, 441-450 (1996) (Pubitemid 26062474)
87. O.T. Johannsson, I. Idvall, C. Anderson, A. Borg, R.B. Barkardottir, V. Egilsson, H. Olsson, Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer 33, 362-371 (1997)
88. S.E. Karp, P.N. Tonin, L.R. Begin, J.J. Martinez, J.C. Zhang, M. N. Pollak, W.D. Foulkes, Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 80, 435-441 (1997) (Pubitemid 27323413)
89. N.D. Kauff, R.R. Barakat, Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J. Clin. Oncol. 25, 2921-2927 (2007) (Pubitemid 47123156)
90. N.D. Kauff, E. Brogi, L. Scheuer, D.R. Pathak, P.I. Borgen, C.A. Hudis, K. Offit, M.E. Robson, Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations. Cancer 97, 1601-1608 (2003) (Pubitemid 36350702)
91. G. Keller, H. Vogelsang, I. Becker, J. Hutter, K. Ott, S. Candidus, T. Grundei, K.F. Becker, J. Mueller, J.R. Siewert, H. Hofler, Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 155, 337-342 (1999) (Pubitemid 29370383)
92. T.A. King, W. Li, E. Brogi, C.J. Yee, M.L. Gemignani, N. Olvera, D.A. Levine, L. Norton, M.E. Robson, K. Offit, P.I. Borgen, J. Boyd, Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Ann. Surg. Oncol. 14, 2510- 2518 (2007) (Pubitemid 47389559)
93. T. Kirchhoff, N.D. Kauff, N. Mitra, K. Nafa, H. Huang, C. Palmer, T. Gulati, E. Wadsworth, S. Donat, M.E. Robson, N.A. Ellis, K. Offit, BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin. Cancer Res. 10, 2918-2921 (2004) (Pubitemid 38619665)
94. L.J. Ko, C. Prives, p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996) (Pubitemid 26152848)
95. E.V. Koonin, S.F. Altschul, P. Bork, BRCA1 protein products. Functional motifs. Nat. Genet. 13, 266-268 (1996)
96. M. Kriege, C. Seynaeve, H. Meijers-Heijboer, J.M. Collee, M. B. Menke-Pluymers, C.C. Bartels, M.M. Tilanus-Linthorst, A. van den Ouweland, B. van Geel, C.T. Brekelmans, J.G. Klijn, Distant disease-free interval, site of first relapse and postrelapse survival in BRCA1-and BRCA2-associated compared to sporadic breast cancer patients. Breast Cancer Res. Treat. 111, 303-311 (2008)
97. A. Kuijper, S.S. Preisler-Adams, F.D. Rahusen, J.J. Gille, E. van der Wall, P.J. van Diest, Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ ovarian cancer. J. Clin. Pathol. 55, 795-797 (2002) (Pubitemid 35231919)
98. S.R. Lakhani, B.A. Gusterson, J. Jacquemier, J.P. Sloane, T.J. Anderson, M.J. van de Vijver, D. Venter, A. Freeman, A. Antoniou, L. McGuffog, E. Smyth, C.M. Steel, N. Haites, R.J. Scott, D. Goldgar, S. Neuhausen, P.A. Daly, W. Ormiston, R. McManus, S. Scherneck, B.A. Ponder, P.A. Futreal, J. Peto, D. Stoppa-Lyonnet, Y.J. Bignon, M.R. Stratton, The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin. Cancer Res. 6, 782-789 (2000) (Pubitemid 30159330)
99. S.R. Lakhani, J. Jacquemier, J.P. Sloane, B.A. Gusterson, T.J. Anderson, M.J. van de Vijver, L.M. Farid, D. Venter, A. Antoniou, A. Storfer-Isser, E. Smyth, C.M. Steel, N. Haites, R. J. Scott, D. Goldgar, S. Neuhausen, P.A. Daly, W. Ormiston, R. McManus, S. Scherneck, B.A. Ponder, D. Ford, J. Peto, D. Stoppa-Lyonnet, Y.J. Bignon, J.P. Struewing, N.K. Spurr, D.T. Bishop, J.G. Klijn, P. Devilee, C.J. Cornelisse, C. Lasset, G. Lenoir, R.B. Barkardottir, V. Egilsson, U. Hamann, J. Chang-Claude, H. Sobol, B. Weber, M.R. Stratton, D.F. Easton, Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst. 90, 1138-1145 (1998) (Pubitemid 28380718)
100. S.R. Lakhani, J.S. Reis-Filho, L. Fulford, F. Penault-Llorca, M. van der Vijver, S. Parry, T. Bishop, J. Benitez, C. Rivas, Y.J. Bignon, J. Chang-Claude, U. Hamann, C.J. Cornelisse, P. Devilee, M.W. Beckmann, C. Nestle-Kramling, P.A. Daly, N. Haites, J. Varley, F. Lalloo, G. Evans, C. Maugard, H. Meijers-Heijboer, J.G. Klijn, E. Olah, B.A. Gusterson, S. Pilotti, P. Radice, S. Scherneck, H. Sobol, J. Jacquemier, T. Wagner, J. Peto, M.R. Stratton, L. McGuffog, D.F. Easton, Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin. Cancer Res. 11, 5175-5180 (2005) (Pubitemid 41003703)
101. S.R. Lakhani, M.J. Van De Vijver, J. Jacquemier, T.J. Anderson, P.P. Osin, L. McGuffog, D.F. Easton, The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J. Clin. Oncol. 20, 2310-2318 (2002) (Pubitemid 34441658)
102. M.F. Lavin, ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26, 7749-7758 (2007) (Pubitemid 350242462)
103. F. Le Page,V. Randrianarison,D.Marot, J. Cabannes,M. Perricaudet, J. Feunteun, A. Sarasin, BRCA1 and BRCA2 are necessary for the transcription- coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res. 60, 5548-5552 (2000)
104. E. Lee, R. McKean-Cowdin, H. Ma, Z. Chen, D. Van Den Berg, B.E. Henderson, L. Bernstein, G. Ursin, Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: Results from a population-based study of young breast cancer patients. Breast Cancer Res. 10, R19 (2008)
105. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, P. Paley, Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol. Oncol. 87, 52-56 (2002) (Pubitemid 36027101)
106. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M.H. Wigler, R. Parsons, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997) (Pubitemid 27148818)
107. F.P. Liebens, B. Carly, A. Pastijn, S. Rozenberg, Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006. Eur. J. Cancer 43, 238-257 (2007) (Pubitemid 46123983)
108. W. Lim, S. Olschwang, J.J. Keller, A.M. Westerman, F.H. Menko, L.A. Boardman, R.J. Scott, J. Trimbath, F.M. Giardiello, S.B. Gruber, J.J. Gille, G.J. Offerhaus, F.W. de Rooij, J.H. Wilson, A.D. Spigelman, R.K. Phillips, R.S. Houlston, Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology 126, 1788-1794 (2004) (Pubitemid 38736344)
109. M.M. Litwiniuk, K. Roznowski, V. Filas, D.D. Godlewski, M. Stawicka, R. Kaleta, J. Breborowicz, Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers. BMC Cancer 8, 100 (2008)
110. K.L. Lorick, J.P. Jensen, S. Fang, A.M. Ong, S. Hatakeyama, A. M. Weissman, RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96, 11364-11369 (1999) (Pubitemid 29487386)
111. B.J. Lynch, J.A. Holden, S.S. Buys, S.L. Neuhausen, D.K. Gaffney, Pathobiologic characteristics of hereditary breast cancer. Hum. Pathol. 29, 1140-1144 (1998) (Pubitemid 28467537)
112. J.N. Marcus, P. Watson, D.L. Page, S.A. Narod, G.M. Lenoir, P. Tonin, L. Linder-Stephenson, G. Salerno, T.A. Conway, H.T. Lynch, Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77, 697-709 (1996) (Pubitemid 26055395)
113. J.N. Marcus, P. Watson, D.L. Page, S.A. Narod, P. Tonin, G.M. Lenoir, O. Serova, H.T. Lynch, BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res. Treat. 44, 275-277 (1997) (Pubitemid 27296388)
114. D.J. Marsh, J.B. Kum, K.L. Lunetta, M.J. Bennett, R.J. Gorlin, S.F. Ahmed, J. Bodurtha, C. Crowe, M.A. Curtis, M. Dasouki, T. Dunn, H. Feit, M.T. Geraghty, J.M. Graham Jr., S.V. Hodgson, A. Hunter, B.R. Korf, D. Manchester, S. Miesfeldt, V.A. Murday, K.L. Nathanson, M. Parisi, B. Pober, C. Romano, C. Eng et al., PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 8, 1461-1472 (1999) (Pubitemid 29374079)
115. S. Matsuoka, M. Huang, S.J. Elledge, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893- 1897 (1998) (Pubitemid 28555269)
116. A. McGaughey, Body image after bilateral prophylactic mastectomy: An integrative literature review. J. Midwifery Womens Health 51, e45-e49 (2006) (Pubitemid 44615967)
117. H. Meijers-Heijboer, A. van den Ouweland, J. Klijn, M. Wasielewski, A. de Snoo, R. Oldenburg, A. Hollestelle, M. Houben, E. Crepin, M. van
118. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, W. Ding et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994) (Pubitemid 24345325)
119. R. Mizuta, J.M. LaSalle, H.L. Cheng, A. Shinohara, H. Ogawa, N. Copeland, N.A. Jenkins, M. Lalande, F.W. Alt, RAB22 and RAB163/mouse BRCA2: Proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. USA 94, 6927-6932 (1997) (Pubitemid 27281967)
120. M. Montagna, M. Dalla Palma, C. Menin, S. Agata, A. De Nicolo, L. Chieco-Bianchi, E. D'Andrea, Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum. Mol. Genet. 12, 1055-1061 (2003) (Pubitemid 36553525)
121. J.R. Morris, C. Boutell, M. Keppler, R. Densham, D. Weekes, A. Alamshah, L. Butler, Y. Galanty, L. Pangon, T. Kiuchi, T. Ng, E. Solomon, The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462, 886-890 (2009)
122. M.E. Moynahan, T.Y. Cui, M. Jasin, Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61, 4842-4850 (2001) (Pubitemid 32691900)
123. S.A. Narod, J. Feunteun, H.T. Lynch, P. Watson, T. Conway, J. Lynch, G.M. Lenoir, Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338, 82-83 (1991)
124. S.A. Narod, W.D. Foulkes, BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer 4, 665-676 (2004) (Pubitemid 39215065)
125. M.R. Nelen, G.W. Padberg, E.A. Peeters, A.Y. Lin, B. van den Helm, R.R. Frants, V. Coulon, A.M. Goldstein, M.M. van Reen, D.F. Easton, R.A. Eeles, S. Hodgsen, J.J. Mulvihill, V.A. Murday, M.A. Tucker, E.C. Mariman, T.M. Starink, B.A. Ponder, H.H. Ropers, H. Kremer, M. Longy, C. Eng, Localization of the gene for Cowden disease to chromosome 10q22-23. Nat. Genet. 13, 114-116 (1996) (Pubitemid 126528240)
126. S. Neuhausen, T. Gilewski, L. Norton, T. Tran, P. McGuire, J. Swensen, H. Hampel, P. Borgen, K. Brown, M. Skolnick, D. Shattuck-Eidens, S. Jhanwar, D. Goldgar, K. Offit, Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet. 13, 126-128 (1996)
127. S.L. Neuhausen, C.J. Marshall, Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54, 6069-6072 (1994) (Pubitemid 24378631)
128. B.L. Niell, G. Rennert, J.D. Bonner, R. Almog, L.P. Tomsho, S. B. Gruber, BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J. Natl. Cancer Inst. 96, 15-21 (2004) (Pubitemid 38180955)
129. C. Oddoux, J.P. Struewing, C.M. Clayton, S. Neuhausen, L.C. Brody, M. Kaback, B. Haas, L. Norton, P. Borgen, S. Jhanwar, D. Goldgar, H. Ostrer, K. Offit, The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat. Genet. 14, 188-190 (1996) (Pubitemid 26338802)
130. K. Offit, T. Gilewski, P. McGuire, A. Schluger, H. Hampel, K. Brown, J. Swensen, S. Neuhausen, M. Skolnick, L. Norton, D. Goldgar, Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347, 1643-1645 (1996) (Pubitemid 26177382)
131. H. Ozcelik, B. Schmocker, N. Di Nicola, X.H. Shi, B. Langer, M. Moore, B.R. Taylor, S.A. Narod, G. Darlington, I.L. Andrulis, S. Gallinger, M. Redston, Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat. Genet. 16, 17-18 (1997)
132. J. Palacios, E. Honrado, J.C. Cigudosa, J. Benitez, ERBB2 and MYC alterations in BRCA1-and BRCA2-associated cancers. Genes Chromosom. Cancer 42, 204-205 (2005). author reply 206
133. J. Palacios, E. Honrado, A. Osorio, A. Cazorla, D. Sarrio, A. Barroso, S. Rodriguez, J.C. Cigudosa, O. Diez, C. Alonso, E. Lerma, J. Dopazo, C. Rivas, J. Benitez, Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res. Treat. 90, 5-14 (2005) (Pubitemid 40486996)
134. J. Palacios, E. Honrado, A. Osorio, A. Cazorla, D. Sarrio, A. Barroso, S. Rodriguez, J.C. Cigudosa, O. Diez, C. Alonso, E. Lerma, L. Sanchez, C. Rivas, J. Benitez, Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: Differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin. Cancer Res. 9, 3606-3614 (2003) (Pubitemid 37169224)
135. K.J. Patel, V.P. Yu, H. Lee, A. Corcoran, F.C. Thistlethwaite, M. J. Evans, W.H. Colledge, L.S. Friedman, B.A. Ponder, A.R. Venkitaraman, Involvement of Brca2 in DNA repair. Mol. Cell 1, 347-357 (1998) (Pubitemid 128378883)
136. T. Peelen, M. van Vliet, A. Petrij-Bosch, R. Mieremet, C. Szabo, A.M. van den Ouweland, F. Hogervorst, R. Brohet, M.J. Ligtenberg, E. Teugels, R. van der Luijt, A.H. van der Hout, J. J. Gille, G. Pals, I. Jedema, R. Olmer, I. van Leeuwen, B. Newman, M. Plandsoen, M. van der Est, G. Brink, S. Hageman, P.J. Arts, M.M. Bakker, P. Devilee et al., A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am. J. Hum. Genet. 60, 1041-1049 (1997) (Pubitemid 27194088)
137. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C. A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C.Williams, S.X. Zhu, P.E. Lonning, A.L. Borresen-Dale, P.O. Brown, D. Botstein, Molecular portraits of human breast tumours. Nature 406, 747-752 (2000)
138. J. Peto, N. Collins, R. Barfoot, S. Seal, W. Warren, N. Rahman, D.F. Easton, C. Evans, J. Deacon, M.R. Stratton, Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J. Natl. Cancer Inst. 91, 943-949 (1999) (Pubitemid 29272520)
139. A. Petrij-Bosch, T. Peelen, M. van Vliet, R. van Eijk, R. Olmer, M. Drusedau, F.B. Hogervorst, S. Hageman, P.J. Arts, M.J. Ligtenberg, H. Meijers-Heijboer, J.G. Klijn, H.F. Vasen, C.J. Cornelisse, L.J. van't Veer, E. Bakker, G.J. van Ommen, P. Devilee, BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet. 17, 341-345 (1997) (Pubitemid 27476002)
140. P.D. Pharoah, A.C. Antoniou, D.F. Easton, B.A. Ponder, Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med. 358, 2796-2803 (2008) (Pubitemid 351930854)
141. K.A. Phillips, K. Nichol, H. Ozcelik, J. Knight, S.J. Done, P.J. Goodwin, I.L. Andrulis, Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J. Natl. Cancer Inst. 91, 469-473 (1999) (Pubitemid 29128285)
142. J.M. Piek, P.J. van Diest, R.P. Zweemer, P. Kenemans, R.H. Verheijen, Tubal ligation and risk of ovarian cancer. Lancet 358, 844 (2001)
143. S.M. Pinilla, E. Honrado, D. Hardisson, J. Benitez, J. Palacios, Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res. Treat. 99, 85-90 (2006) (Pubitemid 44168607)
144. J. Polanowska, J.S. Martin, T. Garcia-Muse, M.I. Petalcorin, S.J. Boulton, A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J. 25, 2178-2188 (2006)
145. N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick, A. Elliott, S. Reid, K. Spanova, R. Barfoot, T. Chagtai, H. Jayatilake, L. McGuffog, S. Hanks, D.G. Evans, D. Eccles, D. F. Easton, M.R. Stratton, PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165-167 (2007) (Pubitemid 46184346)
146. T.R. Rebbeck, Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur. J. Cancer 38(Suppl 6), S15- S17 (2002) (Pubitemid 35284376)
147. G. Rennert, S. Bisland-Naggan, O. Barnett-Griness, N. Bar-Joseph, S. Zhang, H.S. Rennert, S.A. Narod, Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N. Engl. J. Med. 357, 115-123 (2007) (Pubitemid 47057729)
148. A. Renwick, D. Thompson, S. Seal, P. Kelly, T. Chagtai, M. Ahmed, B. North, H. Jayatilake, R. Barfoot, K. Spanova, L. McGuffog, D.G. Evans, D. Eccles, D.F. Easton, M.R. Stratton, N. Rahman, ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet. 38, 873-875 (2006) (Pubitemid 44141653)
149. T. Ripperger, D. Gadzicki, A. Meindl, B. Schlegelberger, Breast cancer susceptibility: Current knowledge and implications for genetic counselling. Eur. J. Hum. Genet. (2008)
150. M.E. Robson, K. Offit, Breast MRI for women with hereditary cancer risk. JAMA 292, 1368-1370 (2004) (Pubitemid 39223232)
151. S.M. Rodriguez-Pinilla, D. Sarrio, E. Honrado, G. Moreno-Bueno, D. Hardisson, F. Calero, J. Benitez, J. Palacios, Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J. Clin. Pathol. 60, 1006-1012 (2007) (Pubitemid 47441933)
152. H. Ruffner, C.A. Joazeiro, D. Hemmati, T. Hunter, I.M. Verma, Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA 98, 5134-5139 (2001) (Pubitemid 32397095)
153. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G. Jaspers, A.M. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins, Y. Shiloh, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753 (1995)
154. K.A. Schrader, S. Masciari, N. Boyd, S. Wiyrick, P. Kaurah, J. Senz, W. Burke, H.T. Lynch, J.E. Garber, D.G. Huntsman, Hereditary diffuse gastric cancer: Association with lobular breast cancer. Fam Cancer 7, 73-82 (2008)
155. M. Schutte, S. Seal, R. Barfoot, H. Meijers-Heijboer, M. Wasielewski, D.G. Evans, D. Eccles, C. Meijers, F. Lohman, J. Klijn, A. van den Ouweland, P.A. Futreal, K.L. Nathanson, B.L. Weber, D.F. Easton, M.R. Stratton, N. Rahman, Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am. J. Hum. Genet. 72, 1023- 1028 (2003) (Pubitemid 36403321)
156. R. Scully, J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, D.M. Livingston, Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275 (1997) (Pubitemid 28015875)
157. R. Scully, D.M. Livingston, In search of the tumoursuppressor functions of BRCA1 and BRCA2. Nature 408, 429-432 (2000)
158. S. Seal, D. Thompson, A. Renwick, A. Elliott, P. Kelly, R. Barfoot, T. Chagtai, H. Jayatilake, M. Ahmed, K. Spanova, B. North, L. McGuffog, D.G. Evans, D. Eccles, D.F. Easton, M.R. Stratton, N. Rahman, Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet. 38, 1239-1241 (2006) (Pubitemid 44646283)
159. S. Shanley, C. Fung, J. Milliken, J. Leary, R. Barnetson, M. Schnitzler, J. Kirk, Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam. Cancer (2009)
160. S.K. Sharan, M. Morimatsu, U. Albrecht, D.S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, A. Bradley, Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810 (1997) (Pubitemid 27181248)
161. A. Sigal, V. Rotter, Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome. Cancer Res. 60, 6788-6793 (2000) (Pubitemid 32059139)
162. J. Simard, P. Tonin, F. Durocher, K. Morgan, J. Rommens, S. Gingras, C. Samson, J.F. Leblanc, C. Belanger, F. Dion et al., Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat. Genet. 8, 392-398 (1994) (Pubitemid 24375607)
163. T.M. Smith, M.K. Lee, C.I. Szabo, N. Jerome, M. McEuen, M. Taylor, L. Hood, M.C. King, Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res. 6, 1029-1049 (1996) (Pubitemid 26413615)
164. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C. M. Perou, P.E. Lonning, P.O. Brown, A.L. Borresen-Dale, D. Botstein, Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100, 8418-8423 (2003) (Pubitemid 36842560)
165. A.D. Spearman, K. Sweet, X.P. Zhou, J. McLennan, F.J. Couch, A.E. Toland, Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance. J. Clin. Oncol. 26, 5393-5400 (2008)
166. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, A. H. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D.H. Teng, S.V. Tavtigian, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362 (1997) (Pubitemid 27147102)
167. M.R. Stratton, D. Ford, S. Neuhasen, S. Seal, R. Wooster, L.S. Friedman, M.C. King, V. Egilsson, P. Devilee, R. McManus et al., Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat. Genet. 7, 103-107 (1994) (Pubitemid 24232389)
168. J.P. Struewing, D. Abeliovich, T. Peretz, N. Avishai, M.M. Kaback, F.S. Collins, L.C. Brody, The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11, 198-200 (1995)
169. K.P. Suijkerbuijk, M.J. Fackler, S. Sukumar, C.H. van Gils, T. van Laar, E. van der Wall, M. Vooijs, P.J. van Diest, Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann. Oncol. 19, 1870-1874 (2008)
170. D.S. Tan, C. Marchio, J.S. Reis-Filho, Hereditary breast cancer: From molecular pathology to tailored therapies. J. Clin. Pathol. 61, 1073-1082 (2008)
171. T. Tapia, S.V. Smalley, P. Kohen, A. Munoz, L.M. Solis, A. Corvalan, P. Faundez, L. Devoto, M. Camus, M. Alvarez, P. Carvallo, Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors. Epigenetics 3, 157-163 (2008)
172. P. Tassone, P. Tagliaferri, A. Perricelli, S. Blotta, B. Quaresima, M.L. Martelli, A. Goel, V. Barbieri, F. Costanzo, C.R. Boland, S. Venuta, BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br. J. Cancer 88, 1285-1291 (2003) (Pubitemid 36606348)
173. D. Thompson, S. Duedal, J. Kirner, L. McGuffog, J. Last, A. Reiman, P. Byrd, M. Taylor, D.F. Easton, Cancer risks and mortality in heterozygous ATM mutation carriers. J. Natl. Cancer Inst. 97, 813-822 (2005) (Pubitemid 40909124)
174. D. Thompson, D. Easton, The genetic epidemiology of breast cancer genes. J. Mammary Gland Biol. Neoplasia 9, 221-236 (2004) (Pubitemid 39545740)
175. S. Thorlacius, G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J. G. Jonasson, S.V. Tavtigian, H. Tulinius, H.M. Ogmundsdottir, J. E. Eyfjord, A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13, 117-119 (1996) (Pubitemid 126528241)
176. T. Thorslund, S.C. West, BRCA2: A universal recombinase regulator. Oncogene 26, 7720-7730 (2007) (Pubitemid 350242452)
177. M. Tirkkonen, O. Johannsson, B.A. Agnarsson, H. Olsson, S. Ingvarsson, R. Karhu, M. Tanner, J. Isola, R.B. Barkardottir, A. Borg, O.P. Kallioniemi, Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res. 57, 1222-1227 (1997) (Pubitemid 27152540)
178. I.P. Tomlinson, M.B. Lambros, R.R. Roylance, Loss of heterozygosity analysis: Practically and conceptually flawed? Genes Chromosom. Cancer 34, 349-353 (2002) (Pubitemid 34787455)
179. P. Tonin, B. Weber, K. Offit, F. Couch, T.R. Rebbeck, S. Neuhausen, A.K. Godwin, M. Daly, J. Wagner-Costalos, D. Berman, G. Grana, E. Fox, M.F. Kane, R.D. Kolodner, M. Krainer, D.A. Haber, J.P. Struewing, E. Warner, B. Rosen, C. Lerman, B. Peshkin, L. Norton, O. Serova, W.D. Foulkes, J.E. Garber et al., Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med. 2, 1179-1183 (1996) (Pubitemid 26375392)
180. R.S. Tuma, Combining carefully selected drug, patient genetics may lead to total tumor death. J. Natl. Cancer Inst. 99, 1505-1506, 1509 (2007)
181. N. Turner, A. Tutt, A. Ashworth, Targeting the DNA repair defect of BRCA tumours. Curr. Opin. Pharmacol. 5, 388-393 (2005) (Pubitemid 40932041)
182. P. Vahteristo, J. Bartkova, H. Eerola, K. Syrjakoski, S. Ojala, O. Kilpivaara, A. Tamminen, J. Kononen, K. Aittomaki, P. Heikkila, K. Holli, C. Blomqvist, J. Bartek, O.P. Kallioniemi, H. Nevanlinna, A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am. J. Hum. Genet. 71, 432-438 (2002) (Pubitemid 34800260)
183. P. Vahteristo, A. Tamminen, P. Karvinen, H. Eerola, C. Eklund, L.A. Aaltonen, C. Blomqvist, K. Aittomaki, H. Nevanlinna, p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition. Cancer Res. 61, 5718-5722 (2001) (Pubitemid 32769084)
184. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, S.H. Friend, Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002) (Pubitemid 34130608)
185. E.H. van Beers, T. van Welsem, L.F. Wessels, Y. Li, R.A. Oldenburg, P. Devilee, C.J. Cornelisse, S. Verhoef, F.B. Hogervorst, L.J. van't Veer, P.M. Nederlof, Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res. 65, 822-827 (2005) (Pubitemid 40216440)
186. P. van der Groep, A. Bouter, F.H. Menko, E. van der Wall, P.J. van Diest, High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. Breast Cancer Res. Treat. 111, 475-480 (2008)
187. P. van der Groep, A. Bouter, R. van der Zanden, F.H. Menko, H. Buerger, R.H.Verheijen, E. van derWall, P.J. van Diest, Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 96, 712-713 (2004). author reply 714
188. P. van der Groep, A. Bouter, R. van der Zanden, I. Siccama, F.H. Menko, J.J. Gille, C. van Kalken, E. van der Wall, R.H. Verheijen, P.J. van Diest, Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J. Clin. Pathol. 59, 611-617 (2006) (Pubitemid 43886045)
189. P. van der Groep, M. Hoelzel, H. Buerger, H. Joenje, J.P. de Winter, P.J. van Diest, Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer. Breast Cancer Res. Treat. 107, 41-47 (2008) (Pubitemid 350179594)
190. P. van der Groep, P.J. van Diest, F.H. Menko, J. Bart, E.G. de Vries, E. van der Wall, Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers. J. Clin. Pathol. 62, 926-930 (2009)
191. P.J. van Diest, P. van der Groep, E. van der Wall, EGFR expression predicts BRCA1 status in patients with breast cancer. Clin Cancer Res 12, 670 (2006). author reply 671 (Pubitemid 43166165)
192. S.A. Vaziri, L.M. Krumroy, P. Elson, G.T. Budd, G. Darlington, J. Myles, R.R. Tubbs, G. Casey, Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. Clin. Cancer Res. 7, 1937-1945 (2001) (Pubitemid 32994828)
193. A.R. Venkitaraman, Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat. Rev. Cancer 4, 266-276 (2004) (Pubitemid 38525282)
194. L.C. Verhoog, C.T. Brekelmans, C. Seynaeve, L.M. van den Bosch, G. Dahmen, A.N. van Geel, M.M. Tilanus-Linthorst, C. C. Bartels, A. Wagner, A. van den Ouweland, P. Devilee, E.J. Meijers-Heijboer, J.G. Klijn, Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351, 316-321 (1998) (Pubitemid 28052696)
195. M.M. Vleugel, A.E. Greijer, A. Shvarts, P. van der Groep, M. van Berkel, Y. Aarbodem, H. van Tinteren, A.L. Harris, P.J. van Diest, E. van der Wall, Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J. Clin. Pathol. 58, 172-177 (2005) (Pubitemid 40193803)
196. B. Vogelstein, D. Lane, A.J. Levine, Surfing the p53 network. Nature 408, 307-310 (2000)
197. Y. Wang, D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, J. Qin, BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927-939 (2000) (Pubitemid 30253002)
198. P.L. Welcsh, M.C. King, BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10, 705-713 (2001) (Pubitemid 32331579)
199. L.F. Wessels, T. van Welsem, A.A. Hart, L.J. van't Veer, M.J. Reinders, P.M. Nederlof, Molecular classification of breast carcinomas by comparative genomic hybridization: A specific somatic genetic profile for BRCA1 tumors. Cancer Res. 62, 7110-7117 (2002) (Pubitemid 35424107)
200. A.K. Wong, R. Pero, P.A. Ormonde, S.V. Tavtigian, P.L. Bartel, RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272, 31941-31944 (1997) (Pubitemid 28011857)
201. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792 (1995) (Pubitemid 26004412)
202. R. Wooster, S.L. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran, D. Averill et al., Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090 (1994) (Pubitemid 24325690)
203. X. Wu, S.R. Webster, J. Chen, Characterization of tumorassociated Chk2 mutations. J. Biol. Chem. 276, 2971-2974 (2001)
204. S.S. Yuan, S.Y. Lee, G. Chen, M. Song, G.E. Tomlinson, E.Y. Lee, BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 59, 3547-3551 (1999) (Pubitemid 29381849)
205. Q. Zhong, C.F. Chen, S. Li, Y. Chen, C.C. Wang, J. Xiao, P.L. Chen, Z.D. Sharp, W.H. Lee, Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285, 747-750 (1999)
206. R.P. Zweemer, P.J. van Diest, R.H. Verheijen, A. Ryan, J.J. Gille, R.H. Sijmons, I.J. Jacobs, F.H. Menko, P. Kenemans, Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol. Oncol. 76, 45-50 (2000) (Pubitemid 30048318)